Physician profile
Robert D Menzies
NPI 1225235179
$85,246.73
in general payments reported to CMS, 2019-2025
57 companies · $15K in 2025
The $15K reported for 2025 was more than what 95% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $10K · 2021: $14K · 2022: $10K · 2023: $11K · 2024: $14K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $37K · Food and Beverage: $1,944 · Travel and Lodging: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $37,373.33 |
| Food and Beverage | $1,943.50 |
| Travel and Lodging | $617.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $75,400.98 | 2019-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Arthrex, INC. | $1,515.00 | 2021 | |
| Pylant Medical | $1,310.07 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $984.20 | 2023-2024 | Iovera, Zilretta, Exparel |
| Abbvie INC. | $687.29 | 2021-2025 | |
| Si-Bone, INC. | $586.04 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $423.34 | 2019-2023 | Relistor |
| Collegium Pharmaceutical, INC. | $330.12 | 2019-2022 | |
| Amgen INC. | $301.69 | 2019-2022 | |
| Zyla Life Sciences, INC. | $256.29 | 2019-2020 | |
| Flowonix Medical Incorporated | $252.25 | 2019-2020 | |
| Boston Scientific Corporation | $244.50 | 2019-2023 | Wavewriter Alpha Prime 16, Varithena Administration Pack |
| Medtronic, INC. | $197.11 | 2021-2024 | Intellis Adaptivestim, Synchromedii |
| Scilex Pharmaceuticals INC. | $195.97 | 2019-2024 | Ztlido |
| Medtronic Vascular, INC. | $189.18 | 2019 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Menzies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.